Skip to main content

Advertisement

SpringerLink
Log in

The Therapeutic Potential of microRNAs in Nervous System Damage, Degeneration, and Repair

  • Original Paper
  • Published:
NeuroMolecular Medicine Aims and scope Submit manuscript

Abstract

MicroRNAS (miRNAs) have been suggested to play important roles in the central nervous system during development as well as disease. miRNAs appear to be dysregulated in a number of neurodegenerative diseases, developmental disorders, and as a result of stroke. Each miRNA has the ability to regulate hundreds of messenger RNA transcripts, both by causing degradation of the mRNA and by inhibition of protein translation. Recent findings suggest that it may eventually be possible to treat some neurological disorders by restoring or inhibiting miRNAs altered by disease pathology. Both viral delivery and administration of modified oligonucleotides mimicking or inhibiting specific miRNAs have been effective in model systems. Artificial miRNAs have also been generated for the repression of specific transcripts. Alteration of miRNA expression by disease and insult also holds the potential for improved diagnostic tools. Finally, miRNAs have been shown to control cellular proliferation and specification, suggesting that manipulation of miRNAs in cultured cells could result in more convenient generation of pure cell populations for transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Abelson, J. F., Kwan, K. Y., O’Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M., et al. (2005). Sequence variants in SLITRK1 are associated with Tourette’s syndrome. Science, 310(5746), 317–320.

    Article  CAS  PubMed  Google Scholar 

  • Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008). The impact of microRNAs on protein output. Nature, 455(7209), 64–71.

    Article  CAS  PubMed  Google Scholar 

  • Beveridge, N. J., Tooney, P. A., Carroll, A. P., Gardiner, E., Bowden, N., Scott, R. J., et al. (2008). Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Human Molecular Genetics, 17(8), 1156–1168.

    Article  CAS  PubMed  Google Scholar 

  • Boissonneault, V., Plante, I., Rivest, S., & Provost, P. (2009). MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. Journal of Biological Chemistry, 284(4), 1971–1981.

    Article  CAS  PubMed  Google Scholar 

  • Boudreau, R. L., Martins, I., & Davidson, B. L. (2009). Artificial microRNAs as siRNA shuttles: Improved safety as compared to shRNAs in vitro and in vivo. Molecular Therapy, 17(1), 169–175.

    Article  CAS  PubMed  Google Scholar 

  • Burmistrova, O. A., Goltsov, A. Y., Abramova, L. I., Kaleda, V. G., Orlova, V. A., & Rogaev, E. I. (2007). MicroRNA in schizophrenia: Genetic and expression analysis of miR-130b (22q11). Biochemistry (Mosc), 72(5), 578–582.

    Article  CAS  Google Scholar 

  • Cao, X., Pfaff, S. L., & Gage, F. H. (2007). A functional study of miR-124 in the developing neural tube. Genes and Development, 21(5), 531–536.

    Article  CAS  PubMed  Google Scholar 

  • Carthew, R. W., & Sontheimer, E. J. (2009). Origins and Mechanisms of miRNAs and siRNAs. Cell, 136, 642–655.

    Article  CAS  PubMed  Google Scholar 

  • Castanotto, D., Sakurai, K., Lingeman, R., Li, H., Shively, L., Aagaard, L., et al. (2007). Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Research, 35(15), 5154–5164.

    Article  CAS  PubMed  Google Scholar 

  • Cataldo, A. M., Petanceska, S., Peterhoff, C. M., Terio, N. B., Epstein, C. J., Villar, A., et al. (2003). App gene dosage modulates endosomal abnormalities of Alzheimer’s disease in a segmental trisomy 16 mouse model of down syndrome. Journal of Neuroscience, 23, 6788–6792.

    CAS  PubMed  Google Scholar 

  • Cockrell, A. S., & Kafri, T. (2007). Gene delivery by lentivirus vectors. Molecular Biotechnology, 36, 184–204.

    Article  CAS  PubMed  Google Scholar 

  • Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., et al. (2008). Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways. Journal of Alzheimer’s Disease, 14(1), 27–41.

    CAS  PubMed  Google Scholar 

  • Conaco, C., Otto, S., Han, J. J., & Mandel, G. (2006). Reciprocal actions of REST and a microRNA promote neuronal identity. Proceedings of the National Academy of Sciences of the United States of America, 103(7), 2422–2427.

    Article  CAS  PubMed  Google Scholar 

  • Croce, C. M., & Calin, G. A. (2005). miRNAs, cancer, and stem cell division. Cell, 122(1), 6–7.

    Article  CAS  PubMed  Google Scholar 

  • De Pietri Tonelli, D., Pulvers, J. N., Haffner, C., Murchison, E. P., Hannon, G. J., & Huttner, W. B. (2008). miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex. Development, 135, 3911–3921.

    Article  PubMed  Google Scholar 

  • Dharap, A., Bowen, K., Place, R., Li, L. C., & Vemuganti, R. (2009). Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. Journal of Cerebral Blood Flow and Metabolism, 29(4), 675–687.

    Article  CAS  PubMed  Google Scholar 

  • Ebert, M. S., Neilson, J. R., & Sharp, P. A. (2007). MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nature Methods, 4(9), 721–726.

    Article  CAS  PubMed  Google Scholar 

  • Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., et al. (2008a). LNA-mediated microRNA silencing in non-human primates. Nature, 452, 896–899.

    Article  PubMed  Google Scholar 

  • Elmén, J., Lindow, M., Silahtaroglu, A., Bak, M., Christensen, M., Lind-Thomsen, A., et al. (2008b). Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Research, 36, 1153–1162.

    Article  PubMed  Google Scholar 

  • Faghihi, M. A., Modarresi, F., Khalil, A. M., Wood, D. E., Sahagan, B. G., Morgan, T. E., et al. (2008). Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of beta-secretase. Nature Medicine, 14(7), 723–730.

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez-Alegre, P., Bode, N., Davidson, B. L., & Paulson, H. L. (2005). Silencing primary dystonia: Lentiviral-mediated RNA interference therapy for DYT1 dystonia. Journal of Neuroscience, 25, 10502–10509.

    Article  CAS  PubMed  Google Scholar 

  • Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., et al. (2006). Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, 441(7092), 537–541.

    Article  CAS  PubMed  Google Scholar 

  • Harper, S. Q., & Gonzalez-Alegre, P. (2008). Lentivirus-mediated RNA interference in mammalian neurons. Methods in Molecular Biology, 442, 95–112.

    Article  CAS  PubMed  Google Scholar 

  • Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., et al. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proceedings of the National Academy of Sciences of the United States of America, 105(17), 6415–6420.

    Article  PubMed  Google Scholar 

  • Hol, E. M., van Leeuwen, F. W., & Fischer, D. F. (2005). The proteasome in Alzheimer’s disease and Parkinson’s disease: Lessons from ubiquitin B+1. Trends in Molecular Medicine, 11, 488–495.

    CAS  PubMed  Google Scholar 

  • Jeyaseelan, K., Lim, K. Y., & Armugam, A. (2008). MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke, 39(3), 959–966.

    Article  CAS  PubMed  Google Scholar 

  • Johnson, R., Zuccato, C., Belyaev, N. D., Guest, D. J., Cattaneo, E., & Buckley, N. J. (2008). A microRNA-based gene dysregulation pathway in Huntington’s disease. Neurobiology of Diseases, 29(3), 438–445.

    Article  CAS  Google Scholar 

  • Kapsimali, M., Kloosterman, W. P., de Bruijn, E., Rosa, F., Plasterk, R. H., & Wilson, S. W. (2007). MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biology, 8(8), R173.

    Article  PubMed  Google Scholar 

  • Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000). Impaired proteasome function in Alzheimer’s disease. Journal of Neurochemistry, 75, 436–439.

    Article  CAS  PubMed  Google Scholar 

  • Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., et al. (2007). A MicroRNA feedback circuit in midbrain dopamine neurons. Science, 317(5842), 1220–1224.

    Article  CAS  PubMed  Google Scholar 

  • Krichevsky, A. M., Sonntag, K. C., Isacson, O., & Kosik, K. S. (2006). Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells, 24, 857–864.

    Article  CAS  PubMed  Google Scholar 

  • Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., et al. (2005). Silencing of microRNAs in vivo with ‘antagomirs’. Nature, 438(7068), 685–689.

    Article  PubMed  Google Scholar 

  • Kumar, P., Wu, H., McBride, J. L., Jung, K. E., Kim, M. H., Davidson, B. L., et al. (2007). Transvascular delivery of small interfering RNA to the central nervous system. Nature, 448(7149), 39–43.

    Article  CAS  PubMed  Google Scholar 

  • Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843–854.

    Article  CAS  PubMed  Google Scholar 

  • Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., et al. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433(7027), 769–773.

    Article  CAS  PubMed  Google Scholar 

  • Lukiw, W. J., Zhao, Y., & Cui, J. G. (2008). An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. Journal of Biological Chemistry, 283(46), 31315–31322.

    Article  CAS  PubMed  Google Scholar 

  • Makeyev, E. V., et al. (2007). The microRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Molecular Cell, 27, 435–448.

    Article  CAS  PubMed  Google Scholar 

  • Mattson, M. P. (2004). Pathways towards and away from Alzheimer’s disease. Nature, 430(7000), 631–639.

    Article  CAS  PubMed  Google Scholar 

  • Mattson, M. P., Maudsley, S., & Martin, B. (2004). BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends in Neurosciences, 27(10), 589–594.

    Article  CAS  PubMed  Google Scholar 

  • McBride, J. L., Boudreau, R. L., Harper, S. Q., Staber, P. D., Monteys, A. M., Martins, I., et al. (2008). Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi. Proceedings of the National Academy of Sciences of the United States of America, 105(15), 5868–5873.

    Article  CAS  PubMed  Google Scholar 

  • Mellios, N., Huang, H. S., Grigorenko, A., Rogaev, E., & Akbarian, S. (2008). A set of differentially expressed miRNAs, including miR-30a–5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Human Molecular Genetics, 17(19), 3030–3042.

    Article  CAS  PubMed  Google Scholar 

  • Miska, E. A., Alvarez-Saavedra, E., Townsend, M., Yoshii, A., Sestan, N., Rakic, P., et al. (2004). Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biology, 5(9):R68.

    Article  PubMed  Google Scholar 

  • Packer, A. N., Xing, Y., Harper, S. Q., Jones, L., & Davidson, B. L. (2008). The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington’s disease. Journal of Neuroscience, 28(53), 14341–14346.

    Article  CAS  PubMed  Google Scholar 

  • Perkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., et al. (2007). microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biology, 8(2), R27.

    Article  PubMed  Google Scholar 

  • Redell, J. B., Liu, Y., & Dash, P. K. (2009). Traumatic brain injury alters expression of hippocampal microRNAs: Potential regulators of multiple pathophysiological processes. Journal of Neuroscience Research, 87(6), 1435–1448.

    Article  CAS  PubMed  Google Scholar 

  • Ren, G., Li, T., Lan, J. Q., Wilz, A., Simon, R. P., & Boison, D. (2007). Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: A novel perspective for seizure control. Experimental Neurology, 208(1), 26–37.

    Article  CAS  PubMed  Google Scholar 

  • Saba, R., Goodman, C. D., Huzarewich, R. L., Robertson, C., & Booth, S. A. (2008). A miRNA signature of prion induced neurodegeneration. PLoS ONE, 3(11), e3652.

    Article  PubMed  Google Scholar 

  • Salehi, A., Delcroix, J. D., Belichenko, P. V., Zhan, K., Wu, C., Valletta, J. S., et al. (2006). Increased App expression in a mouse model of Down’s syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron, 51, 29–42.

    Article  CAS  PubMed  Google Scholar 

  • Sapru, M. K., Yates, J. W., Hogan, S., Jiang, L., Halter, J., & Bohn, M. C. (2006). Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi. Experimental Neurology, 198, 382–390.

    Article  CAS  PubMed  Google Scholar 

  • Schwamborn, J. C., Berezikov, E., & Knoblich, J. A. (2009). The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell, 136(5), 913–925.

    Article  CAS  PubMed  Google Scholar 

  • Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008). Widespread changes in protein synthesis induced by microRNAs. Nature, 455(7209), 58–63.

    Article  CAS  PubMed  Google Scholar 

  • Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., & Ambros, V. (2004). Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biology, 5(3):R13.

    Article  PubMed  Google Scholar 

  • Sheedy, F. J., & O’Neill, L. A. (2008). Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Annals of the Rheumatic Diseases, 67(Suppl 3), iii50–iii55.

    Article  CAS  PubMed  Google Scholar 

  • Silahtaroglu, A. N., Nolting, D., Dyrskjøt, L., Berezikov, E., Møller, M., Tommerup, N., et al. (2007). Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nature Protocols, 2(10), 2520–2528.

    Article  CAS  PubMed  Google Scholar 

  • Singer, O., Marr, R. A., Rockenstein, E., Crews, L., Coufal, N. G., Gage, F. H., et al. (2005). Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nature Neuroscience, 8(10), 1343–1349.

    Article  CAS  PubMed  Google Scholar 

  • Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., et al. (2003). alpha-Synuclein locus triplication causes Parkinson’s disease. Science, 302, 841.

    Article  CAS  PubMed  Google Scholar 

  • Singleton, A., Myers, A., & Hardy, J. (2004). The law of mass action applied to neurodegenerative disease: A hypothesis concerning the etiology and pathogenesis of complex diseases. Human and Molecular Genetics, 13(Spec No 1), R123–R126.

    Article  CAS  Google Scholar 

  • Smirnova, L., Gräfe, A., Seiler, A., Schumacher, S., Nitsch, R., & Wulczyn, F. G. (2005). Regulation of miRNA expression during neural cell specification. European Journal of Neuroscience, 21(6), 1469–1477.

    Article  PubMed  Google Scholar 

  • Tsang, J., Zhu, J., & van Oudenaarden, A. (2007). MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Molecular Cell, 26(5), 753–767.

    Article  CAS  PubMed  Google Scholar 

  • Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008). Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovascular Research, 79(4), 581–588.

    Article  CAS  PubMed  Google Scholar 

  • van Solingen, C., Seghers, L., Bijkerk, R., Duijs, J. M., Roeten, M. K., van Oeveren-Rietdijk, A. M., et al. (2008). Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. Journal of Cellular and Molecular Medicine. 2008 Dec 16. [Epub ahead of print].

  • Várallyay, E., Burgyán, J., & Havelda, Z. (2008). MicroRNA detection by northern blotting using locked nucleic acid probes. Nature Protocols, 3(2), 190–196.

    Article  PubMed  Google Scholar 

  • Wang, W. X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., et al. (2008a). The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. Journal of Neuroscience, 28, 1213–1223.

    Article  PubMed  Google Scholar 

  • Wang, G., van der Walt, J. M., Mayhew, G., Li, Y. J., Züchner, S., Scott, W. K., et al. (2008b). Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. American Journal of Human Genetics, 82, 283–289.

    Article  CAS  PubMed  Google Scholar 

  • Zhao, C., Deng, W., & Gage, F. H. (2008). Mechanisms and functional implications of adult neurogenesis. Cell, 132(4), 645–660.

    Article  CAS  PubMed  Google Scholar 

  • Zhao, C., Sun, G., Li, S., & Shi, Y. (2009). A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nature Structural & Molecular Biology, 16(4), 365–371.

    Article  CAS  Google Scholar 

  • Zhou, R., Yuan. P., Wang, Y., Hunsberger, J. G., Elkahloun, A., Wei, Y., et al. (2009). Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology, 34, 1395–1405.

    Article  CAS  PubMed  Google Scholar 

  • Zuccato, C., Belyaev, N., Conforti, P., Ooi, L., Tartari, M., Papadimou, E., et al. (2007). Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. Journal of Neuroscience, 27, 6972–6983.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Neurosciences, National Institute on Aging Intramural Research Program, Baltimore, MD, 21224, USA

    Emmette R. Hutchison, Eitan Okun & Mark P. Mattson

  2. Brown University Department of Neuroscience, Providence, RI, 02912, USA

    Emmette R. Hutchison

Authors
  1. Emmette R. Hutchison
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eitan Okun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark P. Mattson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark P. Mattson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hutchison, E.R., Okun, E. & Mattson, M.P. The Therapeutic Potential of microRNAs in Nervous System Damage, Degeneration, and Repair. Neuromol Med 11, 153–161 (2009). https://doi.org/10.1007/s12017-009-8086-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12017-009-8086-x

Keywords

Search

Navigation